SAN DIEGO--(BUSINESS WIRE)--In December 2006, The Institute of Cellular Medicine (www.cellmedicine.com) treated a no-option cardiac patient with adult stem cells. Since being treated, the patient has undergone profound recovery, improving his ejection fraction rate from approximately 30% (clinical heart failure) to over 50% which is well within the boundaries of a normal, healthy adult. The Institute of Cellular Medicine recently interviewed the patient to get his perspective on the treatment, his recovery, and outlook on the future.
